Adriamycin 2 mg/mL (Doxorubicin Hydrochloride INJECTION, SOLUTION) 2 mg/mL

Adriamycin 2 mg/mL is a solution for injection containing Doxorubicin Hydrochloride. This medication is commonly used in cancer treatment protocols. Learn more about its uses and effects.

Strength

2 mg/mL

Pack Size

1 VIAL in 1 BOX (0143-9371-01) / 25 mL in 1 VIAL

Manufacturer / TM Owner

Hikma Pharmaceuticals USA Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Adriamycin 2 mg/mL, containing Doxorubicin Hydrochloride, is primarily used in the treatment of various types of cancer. It is often administered intravenously as part of a broader chemotherapy regimen. The medication works by interfering with the growth of cancer cells, helping to slow or stop their proliferation. Patients and healthcare providers often seek information on what Adriamycin is used for, particularly in the context of cancer treatment.

Side Effects

Common effects of Adriamycin 2 mg/mL may include nausea, vomiting, and fatigue. Some patients may experience hair loss or changes in skin color. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise. The effects can vary widely among individuals, depending on the specific cancer treatment protocol.

Precautions & Warnings

Adriamycin 2 mg/mL should be handled with care to avoid contamination. It is crucial to follow proper storage and disposal guidelines to ensure safety. Patients should be aware of potential side effects and discuss any pre-existing conditions with their healthcare provider before starting treatment. Proper administration techniques are essential to minimize risks.

Avoid Interactions

Adriamycin 2 mg/mL may interact with other medications, including those that affect the liver or bone marrow. It is important to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain supplements may also impact the effectiveness or safety of Adriamycin, so patients should exercise caution.

Frequently Asked Questions

Adriamycin 2 mg/mL is used in the treatment of various types of cancer as part of a chemotherapy regimen.

Adriamycin 2 mg/mL is typically administered intravenously by a healthcare professional.

Common side effects may include nausea, vomiting, fatigue, hair loss, and changes in skin color.

Patients should consult their healthcare provider about potential interactions with other medications.

Proper handling, storage, and disposal are crucial. Patients should discuss any pre-existing conditions with their healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.